Engineered Phagemids for Nonlytic, Targeted Antibacterial Therapies

dc.contributor.author	Krom, Russell J
dc.contributor.author	Bhargava, Prerna
dc.contributor.author	Lobritz, Michael A
dc.contributor.author	Collins, James J
dc.date.accessioned	2023-03-01T14:18:43Z
dc.date.available	2023-03-01T14:18:43Z
dc.date.issued	2015-07-08
dc.date.updated	2023-03-01T14:18:43Z
dc.identifier.issn	1530-6984
dc.identifier.issn	1530-6992
dc.identifier.uri	https://hdl.handle.net/10161/26661
dc.language	en
dc.publisher	American Chemical Society (ACS)
dc.relation.ispartof	Nano Letters
dc.relation.isversionof	10.1021/acs.nanolett.5b01943
dc.title	Engineered Phagemids for Nonlytic, Targeted Antibacterial Therapies
dc.type	Journal article
duke.contributor.orcid	Krom, Russell J\|0000-0003-0061-4937
pubs.begin-page	4808
pubs.end-page	4813
pubs.issue	7
pubs.organisational-group	Duke
pubs.organisational-group	School of Medicine
pubs.organisational-group	Clinical Science Departments
pubs.organisational-group	Anesthesiology
pubs.organisational-group	Anesthesiology, Critical Care Medicine
pubs.publication-status	Published
pubs.volume	15

Files

Now showing 1 - 1 of 1